Skip to Main Content

Eric Winer, MD

Alfred Gilman Professor of Pharmacology and Professor of Medicine (Medical Oncology)
DownloadHi-Res Photo

Additional Titles

Director, Yale Cancer Center

President and Physician-in-Chief, Smilow Cancer Hospital

Deputy Dean for Cancer Research, Yale School of Medicine

About

Titles

Alfred Gilman Professor of Pharmacology and Professor of Medicine (Medical Oncology)

Director, Yale Cancer Center; President and Physician-in-Chief, Smilow Cancer Hospital; Deputy Dean for Cancer Research, Yale School of Medicine

Biography

Dr. Eric Winer was appointed Director of Yale Cancer Center and President and Physician-in-Chief of Smilow Cancer Hospital Yale New Haven Health System on February 1, 2022. He is also the Alfred Gilman Professor of Medicine and Pharmacology and Deputy Dean of Cancer Research at Yale School of Medicine. An internationally renowned expert in breast cancer, Dr. Winer has led and collaborated on innumerable clinical trials that have changed the face of the disease. His work has touched almost all aspects of breast cancer and he is particularly well known for his work in HER2 positive disease. Dr. Winer has long been an advocate of building teams consisting of scientists and clinicians to accelerate progress in cancer research and care. He previously served as principal investigator of a breast cancer Specialized Program of Research Excellence (SPORE) for over a decade.

Dr. Winer is a member of the Board for the American Society of Clinical Oncology (ASCO) and a member of the Scientific Advisory Board of the Breast Cancer Research Foundation. For over a decade, he served as chief scientific advisor and chair of the Scientific Advisory Board for Susan G. Komen for the Cure. He co-led the National Cancer Institute Breast Cancer Steering Committee from 2016-2022. Dr. Winer has published over 400 original manuscripts and mentored over 30 fellows and junior faculty. In recognition of his mentoring impact, he was the recipient of the William Silen Lifetime Achievement in Mentoring Award from Harvard Medical School in 2020. He has also received numerous awards for his breast cancer research, most notably the William L. McGuire Memorial Lecture Award in 2016 at the San Antonio Breast Cancer Symposium, the Gianni Bonadonna Breast Cancer Award at ASCO in 2017, the Susan G. Komen Brinker Award for Clinical Research in 2018, and the Jill Rose award from the Breast Cancer Research Foundation in 2019.

Dr. Winer is an alumnus of both Yale College and Yale School of Medicine. After receiving his medical degree in 1983, he completed training in internal medicine and served as chief resident at Yale New Haven Hospital. He completed a fellowship in hematology/oncology at Duke University School of Medicine and served on the Duke faculty from 1989 to 1997. He then joined Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Harvard Medical School where he built an internationally prominent breast cancer program. Prior to his move back to Yale in 2022, he held the Thompson Chair in Breast Cancer Research and served as chief clinical development officer, and senior vice president for medical affairs at Dana-Farber Cancer Institute, as well as Professor of Medicine at Harvard Medical School.

Appointments

  • Medical Oncology

    Chair
    Dual
  • Medical Oncology

    Professor
    Primary

Other Departments & Organizations

Education & Training

Chief Resident
Yale School of Medicine (1987)
Resident
Yale School of Medicine
Intern
Yale School of Medicine (1984)
MD
Yale School of Medicine

Research

Overview

Over the past decade, I have focused on developing new therapies for women with breast cancer and directed more of my attention to basic and translational research. I have secured peer-reviewed funding from the Avon Partners for Progress Program, the Komen Foundation, and the Breast Cancer Research Program.

Medical Research Interests

Breast

Research at a Glance

Yale Co-Authors

Frequent collaborators of Eric Winer's published research.

Publications

2024

Academic Achievements & Community Involvement

  • honor

    William Silen Lifetime Achievement in Mentoring Award

  • honor

    Jill Rose Award for Scientific Excellence

  • honor

    Susan G. Komen Brinker Award for Scientific Distinction in Clinical Research

Clinical Care

Overview

Eric Winer, MD, is the Director of Yale Cancer Center, as well as President and Physician-in-Chief of the Smilow Cancer Hospital Yale New Haven Health System. An internationally renowned medical oncologist and expert in breast cancer, his work has influenced almost all aspects of research and treatment of the disease.

Although he has always divided his time between patient care, research, and mentoring, Dr. Winer’s work as a clinician has driven him to ask research questions and strive to improve all aspects of care. In spite of many advances, there are still far too many individuals with breast cancer who either suffer from the cancer and treatment and sometimes lose their lives. In the United States alone, there are over 40,000 deaths each year, and there are 10 times as many worldwide.

Dr. Winer has long been an advocate of teams that include both scientists and clinicians as a means of accelerating research with the goal of advancing care. “Our mission at Yale is to deliver the best cancer care today and improve that care tomorrow and in the years ahead,” he says.

Dr. Winer is the Alfred Gilman Professor of Medicine and Pharmacology and Deputy Dean of Cancer Research at Yale School of Medicine. He is a past president of the American Society of Clinical Oncology (ASCO) and is a current member and past chair of its board of directors. For more than a decade, he served as chief scientific advisor and chair of the scientific advisory board for Susan G. Komen for the Cure and is now on the scientific advisory board of the Breast Cancer Research Foundation. He will be the board chair in 2025.

Dr. Winer has published over 600 articles, mentored, and has received numerous awards for his breast cancer research. He directed the breast cancer program at Dana-Farber Cancer Institute for over two decades, served as principal investigator of the Dana-Farber/Harvard Specialized Program of Research Excellence (SPORE), and won Harvard Medical School’s lifetime achievement award for mentoring. “I have seen the transformation of cancer care over the past three decades and look forward to even more remarkable advances over the next decade. Yale will continue to play an ever more prominent role in cancer care and research in the years ahead,” he says.

Board Certifications

  • Medical Oncology

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    1989
  • Internal Medicine

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    1987

Yale Medicine News

Get In Touch

Contacts

Appointment Number

Administrative Support

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

Events